Non-pharmacological alternatives to psychotropic medication

Overview

Non-pharmacological alternatives to psychotropic medication (structured psychological therapies, behavioural interventions, environmental/de-escalation strategies) should be actively considered alongside or before medication, particularly in populations at elevated risk from psychotropic adverse effects (older adults, patients with dementia-related behavioural symptoms)
Increasingly emphasised given growing recognition of psychotropic medication overuse/inappropriate use in some populations, particularly antipsychotic use for behavioural and psychological symptoms of dementia, where evidence for benefit is limited and harm (stroke, mortality) risk is elevated

Behavioural and psychological symptoms often reflect an underlying unmet need or trigger (pain, environmental overstimulation, communication difficulty, delirium) rather than a primary psychiatric process requiring pharmacological suppression - addressing the underlying trigger directly (non-pharmacological approach) can resolve the symptom more effectively and safely than medicating the symptom itself

Systematic assessment for reversible triggers/contributors (pain, delirium, environmental factors, unmet needs) should precede or accompany consideration of psychotropic medication for behavioural symptoms, particularly in older adults and patients with cognitive impairment
Structured psychological therapies (CBT and others) have strong evidence for several conditions where medication was historically the default first-line approach (e.g. mild-moderate depression, anxiety disorders)

Behavioural and environmental interventions (structured routine, addressing pain/unmet needs, environmental modification, de-escalation techniques) as first-line for behavioural and psychological symptoms of dementia, given antipsychotics' limited efficacy and significant harm profile (increased stroke and mortality risk) in this population
Psychological therapies as first-line or adjunctive treatment for many mood/anxiety conditions, reducing reliance on medication alone

Antipsychotic use in dementia-related behavioural symptoms (limited efficacy, black-box mortality/stroke warning - a frequently tested example of when non-pharmacological approaches should be prioritised), CBT evidence base for mood/anxiety disorders, addressing reversible triggers before medicating symptoms
Antipsychotic medications used for behavioural and psychological symptoms of dementia carry a well-established, significant increased risk of stroke and mortality with only modest efficacy benefit - non-pharmacological approaches (addressing underlying triggers, environmental modification) should be the first-line approach in this specific population, with antipsychotics reserved for situations where non-pharmacological measures have failed and risk is severe

4 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.